Jean-Manassé Théagenè

Jean-Manassé Théagenè has over twenty (20) years of experience in the life sciences industry serving in diverse roles from global strategy, marketing, commercial operations, licensing, and business development. He has globally marketed multiple blockbuster products, notably with Novartis Oncology and Schering-Plough (Merck). As a serial entrepreneur, Jean-Manassé has been engaged in companion diagnostics, where he launched one of the world’s first non-invasive liver biomarker tests. Jean-Manassé is the founder of 360Medlink, a digital health company serving global clients in the large pharmaceutical, small biotech, and government sectors. As CEO of a healthcare technology company and an early pioneer of Digital Therapeutics (DTx), Jean-Manassé is also a strategic advisor to both private and public agencies in the areas of innovation and healthcare technology.